How long should I hold Eliquis (apixaban) before a moderate‑to‑high bleeding risk dental procedure if I have normal renal function and am on the standard dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long to Hold Eliquis Prior to Dental Procedure

For a moderate-to-high bleeding risk dental procedure in a patient with normal renal function on standard-dose Eliquis, hold the medication for 48 hours (2 days) before the procedure—meaning skip 4 doses and give the last dose 2 days prior to surgery. 1

Risk Classification of Dental Procedures

Most routine dental work falls into the low-to-moderate bleeding risk category and requires only 24 hours of interruption. 2 However, certain dental procedures carry moderate-to-high bleeding risk:

  • Low-risk procedures (24-hour hold): Simple extractions of 1-3 teeth, periodontal surgery, abscess incision, routine cleanings 2, 3
  • Moderate-to-high risk procedures (48-hour hold): Extractions of more than 3 teeth, crown lengthening, open-flap surgery, surgical extractions, extensive periodontal surgery 3

Specific Timing for Eliquis Interruption

For patients on Eliquis 5 mg twice daily with normal renal function:

  • Low-to-moderate bleeding risk dental procedures: Hold for 1 day (24 hours)—last dose on the morning of the day before the procedure 1, 2
  • High bleeding risk dental procedures: Hold for 2 days (48 hours)—last dose 2 days before the procedure, skipping 4 doses total 1

The 2022 American College of Chest Physicians guidelines explicitly state that apixaban should be stopped 1 day before low-to-moderate-bleed-risk procedures and 2 days before high-bleed-risk procedures, regardless of whether the indication is atrial fibrillation or venous thromboembolism. 1

Why Renal Function Doesn't Change Apixaban Timing

Unlike dabigatran, apixaban timing remains constant regardless of kidney function (as long as creatinine clearance is >30 mL/min) because only 25% of the drug depends on renal clearance. 1, 2 The elimination half-life of apixaban is 7-8 hours, so 48 hours allows approximately 6 half-lives to elapse, resulting in >98% drug elimination. 1

Critical Management Points

Do NOT use bridging anticoagulation with heparin or low-molecular-weight heparin when stopping Eliquis for dental procedures—this significantly increases bleeding risk without reducing thrombotic risk. 2, 4

The FDA label for apixaban confirms that the drug "should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding" and "at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding." 5

Resuming Eliquis After the Dental Procedure

Restart Eliquis as early as 6 hours after the dental procedure once adequate hemostasis is established and bleeding has completely ceased. 2, 4 For higher-risk procedures with ongoing oozing, wait at least 24 hours before resumption. 1

Common Pitfalls to Avoid

  • Never perform the procedure if there is any uncertainty about residual drug levels, particularly in elderly patients (>80 years) or those with unrecognized renal impairment 2
  • Provide written instructions specifying the exact date/time of the last Eliquis dose and when to resume therapy 2
  • Do not use INR to monitor Eliquis activity—it does not reliably reflect anticoagulant effect for direct oral anticoagulants 2
  • Assess for drug interactions with P-glycoprotein inhibitors (e.g., dronedarone, amiodarone, verapamil) that can prolong Eliquis elimination 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Management of Eliquis (Apixaban)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Dental Management of Patients Undergoing Antithrombotic Therapy.

Journal (Canadian Dental Association), 2020

Guideline

Perioperative Anticoagulation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.